Siemens Healthineers at ECCMID 2019

Outcomes that Matter.

Siemens Healthineers at ECCMID 2019
 
Bizle İletişime Geçin

At ECCMID 2019, you will learn how Siemens Healthineers is shaping the future of healthcare, so you can drive better outcomes.

Siemens Healthineers offers molecular laboratories over 80 kits covering 140 pathogens. Our large infectious disease menu provides both syndromic panels and singleplex assays.

Explore our latest platform-agnostic solutions for infectious disease testing using the syndromic approach. Meet our experts and learn more about our growing menu of real-time PCR multiplex kits for viruses, bacteria, fungi, and parasites.


Fast Track Diagnostics Products.

Explore our latest molecular solutions for infectious disease testing using the syndromic approach. Meet our experts and learn more about our growing menu of real-time PCR multiplex kits for viruses, bacteria, fungi, and parasites.


Learn more about our molecular IVD assays (Fast Track Diagnostics Assays Now Available!)
Learn more about VERSANT HCV Genotype 2.0 Assay (LiPA) (Now FDA-approved in the US!)

 

*Applied Biosystems and QuantStudio are trademarks of Thermo Fisher Scientific Inc. RUO available in the US.
ATELLICA and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners. Product availability may vary from country to country and is subject to varying regulatory requirements.

1. Under development. Not for sale. Atellica is a registered trademark of Siemens Healthcare Diagnostics Inc.
2. For research use only in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements
3. For research use only in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements
4. FTD assays CE-marked in the EU. For research use only in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements